Transasia highlights the importance of Automation in Clinical Diagnostics
- TSS- Ace is an unique initiative by Transasia Bio-Medicals Ltd. in Tier II and Tier III cities.
- Pathologists and Clinicians discuss on the Latest advances in laboratory automation.
- Receives a welcoming response from over 48 pathologists from Nanded and nearby areas.
Transasia Bio-Medicals Ltd., India’s leading In-vitro Diagnostic Company recently organized a scientific seminar on the latest advancements in clinical diagnostics. Titled Transasia Scientific Seminar (TSS) Ace, this pioneering academic initiative aims at bringing together doctors in Tier II & Tier III cities, thereby encouraging the exchange of technical know-how. This is the first time, that TSS Ace was conducted in Nanded – the city of Gurudwaras. The seminar highlighted biochemistry and hematology-the two most critical areas for in-vitro diagnostics.
The session on ‘Journey from semi-automated to fully automated biochemistry analyzers’ by Dr. Milind Bhide, Managing Director-Bhide Laboratory, Mumbai; focused on the role of automation in increasing lab efficiency and decreasing manual intervention, leading to greater precision. This was followed by a discussion on ‘Shaping Hematology with 6 PDA automation’ led by Dr. Shanaz Khodaiji, Consultant – Dept. of Hematology and Transfusion Medicine, Hinduja Hospital, Mumbai. She emphasized on how the latest technologies assist in precise enumeration of the different parameters, thereby giving an in-depth analysis.
Both the sessions were moderated by Chairperson, Dr Rajendra Mundra , a senior pathologist Practicing in Nanded past 40 years and also the head of Pahologist association of Nanded.
The seminar received an overwhelming response with full-house participation. In fact, the over 48 attendees also comprised pathologists and clinicians from nearby towns such as Latur , Aurangabad , Beed , & usmanabad.The attending Doctors highly appreciated the efforts and demanded more such seminars to be held in the future as well.
Speaking on the occasion Mr. Y.S. Prabhakar, CEO, Transasia Bio-Medicals Ltd. said, “There is an alarming burden on the society from both communicable and non communicable diseases in India. 70% of the treatment decisions are based on lab results. Yet, less than 30% of the Indian population has ever got their blood test done. The major chunk of the 70% population is in the smaller towns. At Transasia, we are committed to reaching out to the pathologists and clinicians in every nook and corner of the country, so that they are well equipped to cater to this population.TSS Ace is a unique platform that empowers the pathologists with the technological advances and encourages exchange of scientific updates, backed by expertise and experience. ”
Over the years, TSS Ace has grown in popularity and has become Transasia’s identity. It has been well accepted as a successful forum and benefits more than 800 pathologists and clinicians annually.